Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Radiopharm Theranostics Limited ( (AU:RAD) ) has shared an announcement.
Radiopharm Theranostics Limited has announced a Share Purchase Plan (SPP) offering eligible shareholders the opportunity to subscribe for up to $30,000 of new shares at an issue price of $0.03 per share. This initiative, which includes a free attaching option for every new share issued, aims to raise $5 million, potentially strengthening the company’s financial position and enabling further development of its radiopharmaceutical products.
The most recent analyst rating on (AU:RAD) stock is a Buy with a A$0.05 price target. To see the full list of analyst forecasts on Radiopharm Theranostics Limited stock, see the AU:RAD Stock Forecast page.
More about Radiopharm Theranostics Limited
Radiopharm Theranostics Limited operates in the medical industry, focusing on the development and commercialization of radiopharmaceutical products for diagnostic and therapeutic purposes. The company aims to leverage its expertise in radiopharmaceuticals to address unmet medical needs and enhance patient care.
Average Trading Volume: 4,552,171
Technical Sentiment Signal: Buy
Current Market Cap: A$87.5M
See more insights into RAD stock on TipRanks’ Stock Analysis page.